HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:B-lymphoblastic leukaemia/lymphoma with iAMP21}} | {{DISPLAYTITLE:B-lymphoblastic leukaemia/lymphoma with iAMP21}} | ||
[[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | [[HAEM5:Table_of_Contents|Haematolymphoid Tumours (WHO Classification, 5th ed.)]] | ||
| Line 8: | Line 7: | ||
Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||